Clicks Don't Fill a Cancer Registry

When a prevention notice is released in Marshallese or ʻŌlelo Hawaiʻi, the clinic knows the appointment was kept only when the registry return field matches the broadcast date. Gomez and colleagues reported widespread breast cancer incidence increases in examined AANHPI populations across the United States, with steep gains among women under 50 and in distant-stage triple-negative plus hormone receptor-negative subtypes the editorial named. Distant-stage rows also rose in subgroup files the editorial warned hospital buyers not to flatten.

Their SEER analysis across 14 states and 9 disaggregated ethnic populations reported incidence rates varying more than threefold, with heavy burden among Native Hawaiian women and rapid recent increases in the Asian Indian, Pakistani, Chinese, Korean, plus Vietnamese subgroups named in the editorial. It is obvious that hospital buyers staffing Pacific-facing health programs need disaggregated incidence files, not one aggregated curve. The editorial tied those patterns to migration, nativity, plus changing exposures across birth cohorts.

In turn, aggregation can mask risk in communities presumed to hold a low burden and can delay interventions tuned to subgroup incidence, stage at diagnosis, plus subtype mix. Gomez and colleagues argued rising distant-stage counts are not explained solely by greater screening volume, which leaves room for missed symptom awareness, delayed follow-up, plus uneven access to mammography and diagnostic imaging. Reference materials describing one aggregated low-risk profile perpetuate the misconception the Gomez paper dismantled.

Meanwhile a separate national cohort study of 68,111 women aged 46 to 64 in the 2024 Behavioral Risk Factor Surveillance Survey, with a median age of 54.8, found only 50.3% up to date on breast, cervical, plus colorectal screening, projecting 17.9 million overdue women nationwide. Asian and Pacific Islander women in that cohort showed a 14% lower likelihood of being current on all three tests compared with White women. Women with a wellness visit in the past year were twice as likely to be current on all three screenings.

Private insurance raised the odds of being current by 54% in that continental cohort. The projected overdue pool included 42.4% behind on more than one test. Another 3.2 million women were behind on all three. For women behind on one test alone, 58% lacked colorectal screening while 22% lacked breast screening and 20% lacked cervical screening. An estimated 8.8 million women behind on breast screening included 72.9% also behind on colorectal or cervical tests. A hospital network buying one poster series for all three modalities cannot tell which gap the flyer closed.

In Honolulu, the John A. Burns School of Medicine Pacific Cancer Programs described a parallel burden across the U.S. Affiliated Pacific Islands. About 415,000 residents occupy hundreds of islands across five time zones. Cervical cancer rates more than double U.S. levels, with the Republic of the Marshall Islands among the highest worldwide. Most Federated States of Micronesia jurisdictions lack mammography. Chemotherapy remains unavailable across much of the region.

Behind that infrastructure gap, health teams rely on village visits and radio broadcasts in places with spotty digital access, deploying visual inspection with acetic acid and clinical breast exams on outer islands while self-collected HPV kits gain ground. Patients referred off-island for oncology may fly to Hawaiʻi, the continental United States, the Philippines, plus Taiwan. Translation into many Pacific tongues remains difficult. A consent form naming the wrong screening modality for a Chuukese listener defeats telehealth follow-up.

Yet after years of assisting hospital systems with patient-facing notices, consent forms, plus screening reminders, client conversations still surface a reporting gap. Teams fund culturally tuned flyers and radio scripts. Few receive structured feedback on whether a Marshallese flyer drove a visual inspection clinic day or whether a Chamorro radio spot changed booking volume. Without an uptake signal tied to the Pacific Regional Central Cancer Registry line or the island tumor registry field, planners cannot tell if distant-stage trends reflect biology, access failure, plus a bulletin never matched to the appointment code.

Which field in the island cancer registry proves the campaign mattered? A public notice may list the correct screening age band yet cite the wrong procedure code for visual inspection with acetic acid versus mammography referral. Match the broadcast identifier to the screening modality logged in the Pacific Regional Central Cancer Registry extract ahead of the coalition report to funders. The mismatch voids the coalition report while hormone receptor-negative and triple-negative subtypes keep rising among younger women Gomez and colleagues flagged.

Across the region, the Cancer Council of the Pacific Islands has sustained community-led direction since 2004, drawing clinical and public health representatives from American Sāmoa, the Commonwealth of the Northern Mariana Islands, Chuuk, Kosrae, Pohnpei, Yap, Guam, Palau, plus the Marshall Islands onto one coalition table. Screening methods became culturally owned when coalitions set priorities first, not when they imported continental poster templates. Outer-island listeners trust village radio over clinic flyers mailed to Honolulu post boxes.

Continental campaigns still treat Asian American, Native Hawaiian, plus Pacific Islander audiences as one bloc. Gomez and colleagues showed why flattening fails clinically. Native Hawaiian incidence patterns differ from Vietnamese or Pohnpei community needs. Subgroup incidence, stage at diagnosis, plus subtype mix should drive which notice ships in which language channel. A wellness-visit prompt lifting U.S. continental rates may never air on the radio block outer-island listeners hear.

For that reason epidemiologic files need disaggregated race and ethnicity fields harmonized across electronic health records and island registries, as the editorial urged. Federal investment in AANHPI clinical research has lagged for more than two decades, leaving sparse subgroup screening and risk-factor data alongside growing multiracial classification problems. Buyers should ask vendors for post-campaign uptake metrics by language channel.

What the registry row must show is a dated screening event, not a click. Tie flyer IDs to completed visual inspection with acetic acid, self-collected HPV returns, plus mammography referrals logged in Hawaiʻi when patients arrive from Majuro or Kolonia. Rising triple-negative trends otherwise look like abstract registry noise and not a failure point in the notice chain. JABSOM reported more diagnosed cases once remote testing expanded. Planners need the screening row to separate detection gains from true incidence change.

Gomez and colleagues also noted limitations buyers should treat as design constraints, including rising not-otherwise-specified case codes, uncertain denominator estimation, plus sparse subgroup screening data in the specialized SEER file. Those gaps shape which populations funders can see and which questions island coalitions can answer when they report to the Pacific Island Health Officers Association. A campaign metric stopping at clicks cannot fill the registry field oncology planners need.

In American Sāmoa, uterine cancer incidence exceeds continental U.S. levels. Liver cancer in Palau surpasses the national average by at least twofold, driven in part by obesity and hepatitis B. Yap and Pohnpei show oral cavity rates tied to betel nut use. A breast notice drafted for Native Hawaiian incidence trends will miss a cervical visual inspection prompt a Chuukese coalition prioritized. Coalition priorities in Chuuk differ from posters drafted for Honolulu mammography campaigns.

Thus surveillance, research, plus clinic action must share one feedback loop. Incidence can climb while screening expands across the USAPI. Buyers must prove which notice moved which modality in which jurisdiction. A hospital network should show its Marshallese consent form produced a dated screening row in the tumor registry. The Pacific Regional Central Cancer Registry line is the field coalition reports should map to flyer IDs.

Until that row exists, buyers fund posters without registry proof. Pacific women keep entering the file at distant stage while younger cohorts accumulate hormone receptor-negative and triple-negative diagnoses Gomez and colleagues flagged. Without data equity, cancer equity will lag for Marshallese and Chamorro communities, plus for Native Hawaiian women named in the editorial incidence tables. Rising not-otherwise-specified case codes in SEER files complicate that coalition audit.